Dr. John Osborne | ClearCardio

Welcome to ClearCardio's Prevention is Power podcast, where we help you take control of your health and protect your future. Today's episode is all about breaking the dangerous myths that keep people from taking action on their heart health. For too long, people have been trapped in outdated false beliefs: waiting for insurance approval, trusting ineffective decades-old tests, or believing heart disease isn't preventable until it's too late.

Dr. John Osborne reveals groundbreaking, unpublished research data from 250 patients that will shatter everything you thought you knew about cholesterol and heart disease. Using the most sensitive plaque detection technology available, this study proves that traditional cholesterol markers—including LDL, HDL, and total cholesterol—have ZERO predictive ability for determining who has plaque or how much plaque they have. This episode exposes the dangerous inadequacy of stress tests and EKGs, reveals why insurance gatekeeping keeps you from life-saving care, and explains why pharmaceutical companies can't solve a problem that isn't being properly diagnosed in the first place.

"The future's already here. It's just not equally distributed. We have all the solutions to eliminate heart disease. We don't have to wait. Other people may, but all you have to do is reach out." — Dr. John Osborne

---

Key Takeaways from This Episode:

• MYTH BUSTED: Unpublished research on 250 patients proves that LDL ("bad" cholesterol), HDL ("good" cholesterol), total cholesterol, and triglycerides have NO predictive ability for determining who has plaque or how much plaque they have.

• MYTH BUSTED: You do NOT need insurance approval or doctor referrals to get advanced cardiac imaging—you can take control of your health directly by going to preventive specialists.

• MYTH BUSTED: Stress tests and EKGs are dangerously outdated, with stress tests missing 25% of severe blockages and only detecting disease when vessels are 70%+ blocked—far too late for prevention.

• MYTH BUSTED: The HDL "good cholesterol" myth was disproven 20 years ago. High HDL levels can actually be pro-plaque and increase cardiovascular risk.

• AI-powered cardiac CT can analyze over 2,000 shades of gray in millions of pixels, detecting plaque invisible to the human eye and quantifying it down to a tenth of a cubic millimeter.

• Cholesterol measurement only tells you what's floating in your bloodstream, not whether it's sticking to your vessel walls—the only thing that matters for disease formation.

• You can have high cholesterol with "Teflon" arteries (no plaque formation) or low cholesterol with "Velcro" arteries (significant plaque formation).

• Patients hospitalized for coronary artery disease actually had LOWER average LDL cholesterol than the general population, proving cholesterol levels don't predict disease.

• LP(a) is a 100% genetic "hidden cholesterol" affecting 20% of heart disease patients that isn't detected on standard cholesterol panels and must be specifically tested.

• The medical system waits until you have 70%+ blockages requiring mechanical intervention, missing a 30-year window for early detection and prevention.

Resources Mentioned:

• ClearCardio Advanced AI-Powered Cardiac Imaging: clearcardio.com

• LP(a) Testing for Hidden Genetic Cholesterol

• APOB Testing (Advanced Cholesterol Marker)

• Understanding the Limitations of Traditional Heart Testing

• Direct-Pay Preventive Cardiology Services

• Cardiac CT vs. Traditional Stress Testing Comparison